Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population

Cancer Science

Volumn 102, Issue 10, 2011, Pages 1782-1788

  Yamada, Hidetaka ^a   Shinmura, Kazuya ^a   Ito, Hiroaki ^b   Kasami, Masako ^c   Sasaki, Naomi ^d   Shima, Hideyuki ^d   Ikeda, Masami ^e   Tao, Hong ^a   Goto, Masanori ^a   Ozawa, Takachika ^f   Tsuneyoshi, Toshihiro ^g   Tanioka, Fumihiko ^h   Sugimura, Haruhiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY NORTHERN YOKOHAMA HOSPITAL   (Japan)

^c SHIZUOKA CANCER CENTER   (Japan)

^d Kure Kyosai Hospital   (Japan)

^e Asama General Hospital   (Japan)

^f HAMAMATSU MEDICAL CENTER   (Japan)

^g SHIZUOKA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^h Iwata City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; UVOMORULIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL ADHESION; CLINICAL ARTICLE; EXON; FAMILIAL GASTRIC CANCER; GENE DELETION; GENE MUTATION; GENE REARRANGEMENT; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STOMACH CANCER; WILD TYPE;

ANIMALS; BASE SEQUENCE; CADHERINS; CELL ADHESION; CELL LINE; CHO CELLS; CRICETINAE; FRAMESHIFT MUTATION; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; JAPAN; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; STOMACH NEOPLASMS;

EID: 80053384879     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02038.x     Document Type: Article

References (30)

1. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Publ 2004; (157) 327-49.
2. Humar B, Guilford P. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci 2009; 100: 1151-7.
3. Guilford P, Humar B, Blair V. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer 2010; 13: 1-10.
4. Tamura G, Sakata K, Nishizuka S et al. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res 1996; 87: 1153-9.
5. Brooks-Wilson AR, Kaurah P, Suriano G et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004; 41: 508-17.
6. More H, Humar B, Weber W et al. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat 2007; 28: 203.
7. Shinmura K, Kohno T, Takahashi M et al. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 1999; 20: 1127-31.
8. Iida S, Akiyama Y, Ichikawa W et al. Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindreds. Clin Cancer Res 1999; 5: 1445-7.
9. Yabuta T, Shinmura K, Tani M et al. E-cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int J Cancer 2002; 101: 434-41.
10. Wang Y, Song JP, Ikeda M, Shinmura K, Yokota J, Sugimura H. Ile-Leu substitution (I415L) in germline E-cadherin gene (CDH1) in Japanese familial gastric cancer. Jpn J Clin Oncol 2003; 33: 17-20.
11. Nakagawa H, Hampel H, de la Chapelle A. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques. Hum Mutat 2003; 22: 258.
12. Gomez-Fernandez N, Castellvi-Bel S, Fernandez-Rozadilla C et al. Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations? BMC Med Genet 2009; 10: 57.
13. Hogervorst FB, Nederlof PM, Gille JJ et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 2003; 63: 1449-53.
14. Oliveira C, Senz J, Kaurah P et al. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009; 18: 1545-55.
15. Yamada H, Shinmura K, Ikeda S et al. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population. Scand J Gastroenterol 2007; 42: 1479-85.
16. Yamada H, Shinmura K, Goto M et al. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients. Mol Cancer 2009; 8: 63.
17. Suriano G, Oliveira C, Ferreira P et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet 2003; 12: 575-82.
18. Shiraishi K, Tsuzaka K, Yoshimoto K et al. Critical role of the fifth domain of E-cadherin for heterophilic adhesion with αEβ7, but not for homophilic adhesion. J Immunol 2005; 175: 1014-21.
19. Shinmura K, Igarashi H, Goto M et al. Aberrant expression and mutation-inducing activity of AID in human lung cancer. Ann Surg Oncol 2011; 18: 2084-92.
20. Boterberg T, Bracke ME, Bruyneel EA, Mareel MM. Cell aggregation assays. Methods Mol Med 2001; 58: 33-45.
21. Suriano G, Seixas S, Rocha J, Seruca R. A model to infer the pathogenic significance of CDH1 germline missense variants. J Mol Med 2006; 84: 1023-31.
22. Cisco RM, Ford JM, Norton JA. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer 2008; 113: 1850-6.
23. Palli D. Epidemiology of gastric cancer. Ann Ist Super Sanita 1996; 32: 85-99 (In Italian.).
24. Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 2008; 47: 1077-83.
25. Kim IJ, Park JH, Kang HC et al. A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer. J Med Genet 2003; 40: e97.
26. Oliveira C, Ferreira P, Nabais S et al. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer 2004; 40: 1897-903.
27. Shinmura K, Goto M, Tao H et al. A novel STK11 germline mutation in two siblings with Peutz-Jeghers syndrome complicated by primary gastric cancer. Clin Genet 2005; 67: 81-6.
28. Yamada H, Shinmura K, Okudela K et al. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population. Carcinogenesis 2007; 28: 2013-8.
29. Capelle LG, Van Grieken NC, Lingsma HF et al. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 2010; 138: 487-92.
30. Papp J, Kovacs ME, Olah E. Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing. World J Gastroenterol 2007; 13: 2727-32.